Reducing Lesbian, Gay , Bisexual and Transgender (LGBT) Stigma in Swaziland and Lesotho

NCT ID: NCT02410434

Last Updated: 2016-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

106 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The specific objectives of this study are reduce stigma towards lesbian, gay, bisexual, and transgender persons in Swaziland and Lesotho, using performance ethnography at community roundtables.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project aims to develop performance ethnography approaches to reduce stigma towards lesbian, gay, bisexual and transgender (LGBT) persons in Swaziland and Lesotho by holding performance ethnography at community roundtables in Swaziland and Lesotho.

This project involved a critical ethnography with in-depth individual interviews conducted with LGBT communities in Swaziland and Lesotho. Following this, the investigators conducted a performance ethnography that involved: a) presenting theatre specialists and PRAs with the qualitative data; b) working together to highlight narratives, themes and visual images from this data; c) developing scripts for participatory theatre performances; d) implementing the theatre performances at community roundtables, with participants completing a pre and post-test and 6 week follow up.

The investigators will implement 2 interconnected KTE strategies in each location (Swaziland, Lesotho): (1) participatory theatre (PT) training/development and (2) community roundtables. (1) Participatory theatre (PT) training with SGM: The investigators will engage 6 SGMY (2 MSM, 2 WSW, 2 transgender) as PRA in each location. PRA will work with a theatre specialist to develop 3 short plays to highlight lived experiences of a) stigma and discrimination and b) resilience among MSM, WSW and trans persons. PRA will undertake a 4-week PT training program, including: PT processes; assessing. Phase 1 data; developing scenes; and production. PRA will work with community animators who will perform the scenarios to protect the privacy of the PR.

The investigators will implement community roundtables are to: a) raise awareness of SGM issues and b) reduce stigma. Purposive sampling will be employed to engage diverse stakeholders. Roundtables, 2 hours in duration, will be cofacilitated by PRA. The aim is to conduct 2 meetings in Swaziland and 2 in Lesotho, each with 20-25 participants, including groups identified as key to SGM wellbeing in Phase 1 (e.g. educators; law enforcement; civil society; LGBTQ groups). Community animators will enact the 3 plays developed by SGM using PT techniques. Plays will address narratives of stigma and discrimination that emerge in Phase 1 among SGM participants. Community animators will perform each play once to illustrate the situation and problem; the story will culminate in a crisis with no solution offered. Each play will be performed a second time, and roundtable participants can 'stop' the action at any point where there is a challenge. The participant that 'stops' the play will come up and replace the character and depict a possible solution or 'intervention.

To evaluate the project's outcomes the investigators will conduct cross-sectional surveys with roundtable participants (n=100) who will complete a pre/post-test evaluation and 6 week follow up. The primary outcome will be measured using the 'Attitudes Towards Lesbians and Gay Men Scale' (ATLG-R) to assess changes in phobia, stigma and knowledge regarding SGM issues following the participatory theatre event. The survey will also include questions about attitudes towards HIV related stigma. Socio-demographic information will be collected from all survey participants including age, gender, highest level of education, nationality, marital status, current household income, type of work, number of children, and religion. MANOVA will be used to assess pre/post-test differences across variables.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Social Stigma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LGBT Stigma Reduction Intervention

Participants will complete a pre-test, followed by a performance ethnography where they will watch theatre performances that illustrate stigma experienced by LGBT persons in Swaziland and Lesotho. They will have the opportunity to participate in these theatre performances to demonstrate reduced stigma and increased acceptance of LGBT persons. They will then complete a post-test, followed by a 6 week follow up survey.

Group Type EXPERIMENTAL

LGBT Stigma Reduction Intervention

Intervention Type OTHER

Participants will complete a pre-test, followed by a performance ethnography where they will watch theatre performances that illustrate stigma experienced by LGBT persons in Swaziland and Lesotho. They will have the opportunity to participate in these theatre performances to demonstrate reduced stigma and increased acceptance of LGBT persons. They will then complete a post-test, followed by a 6 week follow up survey.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LGBT Stigma Reduction Intervention

Participants will complete a pre-test, followed by a performance ethnography where they will watch theatre performances that illustrate stigma experienced by LGBT persons in Swaziland and Lesotho. They will have the opportunity to participate in these theatre performances to demonstrate reduced stigma and increased acceptance of LGBT persons. They will then complete a post-test, followed by a 6 week follow up survey.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must be 18 years of age or older for being able to give informed consent and be willing to complete a follow up survey.

Exclusion Criteria

* Participants who are 17 years of age or younger were exuded for not being able to give informed consent.
* Participants who were unwilling to complete a follow up survey were also excluded.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carmen Logie, MSW, PhD

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carmen Logie, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Toronto, Factor-Inwentash Faculty of Social Work

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern Africa Nazarene University

Manzini, , Eswatini

Site Status

Maluti School of Nursing

Maseru, , Lesotho

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Eswatini Lesotho

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

#30344

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.